Singapore Deep-Tech Capital Rose as Deals Fell—Three Tests for Going Global
Singapore’s deep-tech market delivered a revealing contrast in 2025: investment value increased 16% to US$1.133 billion, while the number of deals fell 27% to 91. The Singapore Venture Funding Landscape Report 2025 also shows that deep tech reached 24.7% of the country’s total venture deal value, suggesting that capital became more concentrated in companies with differentiated technology and credible commercialization paths.
The enduring lesson is that deep-tech startups often need international customers, infrastructure and capital. What has become clearer is that expansion should follow evidence rather than ambition alone: founders need to prove why a specific market matters, determine what must operate locally and finance measurable technical and commercial milestones. The following three tests turn that principle into a practical cross-border plan.
1. Choose a market around one decisive proof point
A large economy is not automatically the right first destination. Select the country where one unresolved assumption can be tested most clearly: whether a regulated buyer will adopt the product, whether an industrial partner can integrate it, whether the unit economics survive local deployment or whether specialist talent can remove a technical bottleneck.
Recent Singapore examples show how specific that logic can be. Enterprise Singapore’s account of US expansion says robotics company Augmentus opened an Austin office in 2024 in response to US customer demand, while medtech company Aevice Health chose the United States partly because FDA clearance permits nationwide marketing of a medical device. Bifrost AI, by contrast, located in San Francisco for proximity to robotics companies and venture investors. These were different products solving different access problems, not interchangeable endorsements of one fashionable hub.
Before committing to an office, founders should write a one-sentence market thesis: “We are entering this country to prove X with buyer or partner Y by date Z.” The evidence required should be harder than expressions of interest. Depending on the product, it could be a paid pilot, a procurement qualification, a regulatory submission accepted for review, repeatable manufacturing yield or a signed development agreement with defined responsibilities.
- Identify the buyer with authority and budget, not merely an enthusiastic technical contact.
- Confirm who bears installation, validation, servicing and liability costs.
- Estimate the time from first trial to recognized revenue under local procurement rules.
- Define the result that would justify further hiring—and the result that would stop expansion.
This test protects scarce engineering time. A market visit may produce useful conversations, but it should not become a permanent operation until the company knows which commercial uncertainty the operation is meant to resolve.
2. Design the operating model before registering the entity
A foreign subsidiary is an administrative container, not an expansion strategy. First map the activities that must cross the border: transfer of prototypes, access to source code or research data, employment of specialist staff, clinical or industrial testing, customer support and movement of revenue. Each flow can create a different legal, tax, security or operational dependency.
The central decision is what must remain with the core company and what must be placed near the customer. Intellectual-property ownership, architecture and platform engineering may remain centralized, while field integration, regulatory work and account management sit in-market. Hardware businesses may also need local repair capacity or a qualified manufacturing partner because a distant engineering team cannot satisfy every uptime obligation.
Founders should create a border map covering five elements: intellectual property, regulated approvals, data access, controlled technology or components, and contractual liability. It should name an accountable owner for each element and record where expert advice is still required. This is especially important in dual-use, semiconductor, aerospace, health and advanced-computing businesses, where a technically simple transfer may still face export, security or certification constraints.
The first local hire should match the proof point from the first test. If adoption depends on system integration, a technically credible applications lead may be more useful than a general country manager. If procurement is the constraint, the company may need someone who understands the buyer’s approval chain. A prestigious résumé cannot compensate for a network that is irrelevant to the actual customer, regulator or supply chain.
Governance must remain explicit as the remote team grows. Decide who can promise product changes, sign pilots, select distributors and commit engineering resources. Give local leaders enough authority to respond to the market, but require decisions to be recorded against technical capacity, cash and the company’s shared product roadmap.
3. Finance milestones, not a collection of flags
Cross-border growth consumes capital before it reliably produces revenue. Entity formation, regulatory work, localized testing, senior hires and inventory can overlap with the original research program. A financing plan should therefore connect every overseas expense to a milestone that improves technical readiness, customer evidence or investability.
Current European support illustrates this milestone-based approach. The official EIC Accelerator programme offers grants below €2.5 million for technology-readiness-level 6–8 work intended to finish within 24 months, plus an investment component of €1 million to €10 million. Its eligibility rules also matter to cross-border founders: applicants from third countries may need to relocate the company before submitting a full application, while UK applicants are limited to the grant-only route.
The practical implication extends beyond that programme. Funding jurisdiction, corporate location and target customers are related decisions, but they should not be collapsed into one. A founder may discover strong demand in one country, suitable non-dilutive support in another and essential manufacturing capability in a third. The company needs a deliberate structure for connecting them, not three lightly staffed offices competing for the same cash.
Build a financing schedule around observable gates: prototype performance, certification progress, paid deployment, manufacturing repeatability and customer renewal. Include the cash needed to reach each gate, the evidence investors will receive and a fallback if approval or procurement takes longer than expected. This makes the international plan legible to both the board and prospective funders.
Putting the three tests into one expansion decision
The tests should run in sequence but inform one another. Market evidence determines the local operating requirements; those requirements reveal the true capital need. If the cost of satisfying local regulation and service obligations overwhelms the value of the available customer proof, the market may be attractive but premature.
- Frame the proof: choose one market, one consequential uncertainty and one result that would warrant deeper investment.
- Map the operation: assign ownership for intellectual property, approvals, data, controlled technology, customer delivery and local authority.
- Fund the gates: budget through the next technical and commercial milestones, with explicit stop conditions and schedule contingencies.
Going global early does not require operating everywhere. For a deep-tech startup, the stronger strategy is to cross one border for a defined reason, earn evidence that survives scrutiny, and expand the footprint only when that evidence justifies the next commitment.
Also read:
Subscribe to our newsletter
Get the latest Web3, AI, and crypto news delivered straight to your inbox.